The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: more questions than answers.
Kerem
E
E
Department of Pediatrics, Shaare Zedek Medical Center, Jerusalem, Israel.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D007223:Infant; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000382:microbiology*; D011379:Prognosis; D011552:Pseudomonas Infections / Q000175:diagnosis* / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D012129:Respiratory Function Tests; D012720:Severity of Illness Index; D013183:Sputum / Q000382:microbiology
D000900:Anti-Bacterial Agents